Launch week offerEnds in00h00m00s

annual Promonthly Pro

Laurent Derré

Head of the Urology Research Unit and Urology Biobank

Lausanne University Hospital

Switzerland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Articles (10)

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (6)

Thierry Roger

Associate Professor

Université de Lausanne Faculté de biologie et de médecine

SWITZERLAND

View details

Amber Bowler

EPFL (École Polytechnique Fédérale de Lausanne)

SWITZERLAND

View details

LANA E. KANDALAFT

Associate Professor

University of Lausanne

SWITZERLAND

View details

Sylvain Nguyen

University of Oxford

UNITED KINGDOM

View details

Irina Banzola

University Hospital of Zurich

SWITZERLAND

View details

Beat Roth

Lausanne University Hospital

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Laurent Derré

Research Interests

Make your next move.

Explore related searches

Articles (10)

Unconventional T cells in urological cancers: catch them if you can

Characterization of Ty21a immunostimulatory effects in the mouse bladder

Editorial: Understanding bladder tumor microenvironment to optimize immunotherapy.

Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy.

Immunomonitoring in bladder cancer: a short report on stability of leukocytes and proteins in refrigerated urine samples.

The role of preoperative immunonutrition on morbidity and immune response after cystectomy: protocol of a multicenter randomized controlled trial (INCyst Trial).

UROPOT: study protocol for a randomized, double-blind phase I/II trial for metabolism-based potentiation of antimicrobial prophylaxis in the urological tract.

Myeloid-Derived Suppressive Cells in the Tumor Contexture

Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer

Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential

Collaborators (6)

Thierry Roger

Amber Bowler

LANA E. KANDALAFT

Sylvain Nguyen

Irina Banzola

Beat Roth

Make your next move.